Zacks.com on MSN1h
IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock FallsIronwood Pharmaceuticals, Inc. IRWD announced that it has initiated the rolling new drug application (“NDA”) submission for ...
22h
We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...
Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback